Navigation Links
'Dead' Human Embryo – Source of stem cell

Researchers have acquired a stem cell line from a lifeless human embryo. Ethical issues may not be raised as these embryos have stopped developing naturally//.

The study and treatment of diseases like diabetes and Parkinson’s involving human embryonic stem cells has raised ethical concerns due to the controversial method of obtaining and harvesting human embryos.

Researcher Miodrag Stojkovic said, "The study shows that dead embryos provide an additional source of the cells beyond healthy embryos, rather than to set up any kind of a competition."
The work is considered to be an important addition to the field by Dr. Donald W. Landry, director of the division of experimental therapeutics at the Columbia University Medical Center. Landry said, "Regardless of how you feel about personhood for embryos, if the embryo is dead, then the issue of personhood is resolved." "This then reduces the ethics of human embryonic stem cell generation to the ethics of, say, organ donation. So now you're really saying, `Can we take live cells from dead embryos the way we take live organs from dead patients?'"

The Rev. Tad Pacholczyk, director of education for the National Catholic Bioethics Center said, "I believe an embryo could still be alive if individual cells can still develop stem cell lines. "
At the same time, Dr. George Daley of the Harvard Stem Cell Institute was concerned about the method of the study. "If there was something wrong with the embryo that made it arrest, isn't there something wrong with these cells, he asked. "We don't know."
GYT
'"/>




Page: 1

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Human gene number increases
4. Scientists found ancient Human Germ Killer
5. New standards for Human Research Safety
6. Human wasting disease linked to a gene
7. The Human Mad Cow Case
8. Human Growth Hormone Found To be Dangerous For Human Use
9. Human Antibody That Can Block SARS
10. Human immunity system can battle HIV.
11. Two New Human Papilloma virus (HPV) vaccines to prevent cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dead Human Embryo Source stem cell

Other Medicine Technology:Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7